SCHEMBL7913246

SCHEMBL7913246

C[Si](C)(Cl)c1ccc(Cl)cc1

nearest known ligand 0.47

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.47
CYP2A6 P11509 1/20 0.47
IDO1 P14902 2/20 0.36
MEN1 O00255 1/20 0.35
KMT2A Q03164 1/20 0.35
ADRB2 P07550 1/20 0.35
NOTUM Q6P988 4/20 0.34
KDM4E B2RXH2 2/20 0.33
TSHR P16473 2/20 0.33
ALDH1A1 P00352 1/20 0.33
CYP1A2 P05177 1/20 0.33
HDAC8 Q9BY41 1/20 0.33
NR1H4 Q96RI1 1/20 0.32
CYP19A1 P11511 3/20 0.32
NPC1 O15118 1/20 0.32
TP53 P04637 1/20 0.32
RAB9A P51151 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HSD17B10 Q99714 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL705667 0.87 ALDH1A1 (0.36) ALDH1A1
SCHEMBL6477550 0.82 LMNA (0.47) LMNACYP2A6IDO1MEN1KMT2A
SCHEMBL20455818 0.82 LMNA (0.47) LMNACYP2A6IDO1MEN1KMT2A
SCHEMBL196503 0.79 LMNA (0.50) LMNACYP2A6IDO1MEN1KMT2A
SCHEMBL30965311 0.79 ESR1 (0.44)
SCHEMBL10318540 0.79 NR1H2 (0.41)
SCHEMBL801429 0.79
SCHEMBL80628 0.77 ACHE (0.47) LMNAMEN1KMT2ANOTUMKDM4E
SCHEMBL10623477 0.75 LMNA (0.53) LMNACYP2A6IDO1TSHRALDH1A1
SCHEMBL8372965 0.75 LMNA (0.53) LMNACYP2A6IDO1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-62108885-A None JP disclosed
US-9919300-B2 1-hexene production process SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2018-03-20 US disclosed
EP-2484685-B1 TRANSITION METAL COMPLEX, PREPARATION METHOD FOR SAID TRANSITION METAL COMPLEX, TRIMERIZATION CATALYST, PREPARATION METHOD FOR 1-HEXENE, PREPARATION METHOD FOR ETHYLENE POLYMER, SUBSTITUTED CYCLOPENTADIENE COMPOUND, AND PREPARATION METHOD FOR SAID SUBSTITUTED CYCLOPENTADIENE COMPOUND SUMITOMO CHEMICAL CO (JP) 2017-11-01 EP disclosed
US-20170036200-A1 1-HEXENE PRODUCTION PROCESS SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-02-09 US disclosed
US-20150105572-A1 TRANSITION METAL COMPLEX SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-04-16 US disclosed
US-20150105237-A1 CATALYTIC COMPONENT FOR TRIMERIZATION AND TRIMERIZATION CATALYST SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-04-16 US disclosed
EP-2484685-A1 TRANSITION METAL COMPLEX, PREPARATION METHOD FOR SAID TRANSITION METAL COMPLEX, TRIMERIZATION CATALYST, PREPARATION METHOD FOR 1-HEXENE, PREPARATION METHOD FOR ETHYLENE POLYMER, SUBSTITUTED CYCLOPENTADIENE COMPOUND, AND PREPARATION METHOD FOR SAID SUBSTITUTED CYCLOPENTADIENE COMPOUND Sumitomo Chemical Co., Ltd (JP) 2012-08-08 EP disclosed
US-20120184431-A1 TRANSITION METAL COMPLEX, PREPARATION METHOD FOR SAID TRANSITION METAL COMPLEX, TRIMERIZATION CATALYST, PREPARATION METHOD FOR 1-HEXENE, PREPARATION METHOD FOR ETHYLENE POLYMER, SUBSTITUTED CYCLOPENTADIENE COMPOUND, AND PREPARATION METHOD FOR SAID SUBSTITUTED CYCLOPENTADIENE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-07-19 US disclosed
US-6207846-B1 REACTING 3-ARYL-1,1,2-TRIFLUORO-1-PROPENE WITH A REDUCING AGENT; THEN A LITHIUM BASE; THEN ARYLCHLOROSILANE COMPOUND AMERICAN CYANAMID CO. 2001-03-27 US disclosed
US-6159956-A Process and intermediate compounds for the preparation of difluorovinylsilane insecticidal and acaricidal agents AMERICAN CYANAMID CO. (US) 2000-12-12 US disclosed
EP-0577139-B1 Method for preparing triorganomonohalogenosilane SHINETSU CHEMICAL CO (JP) 1998-10-21 EP disclosed
EP-0432905-B1 Polysilphenylenesiloxane, production process thereof, and resist material and semiconductor device formed thereof FUJITSU LTD (JP) 1998-02-04 EP disclosed
US-5484687-A PHOTORESISTS, THREE-DIMENSIONAL, POLYSILSESQUIOXANES FUJITSU LIMITED (JP) 1996-01-16 US disclosed
US-5342984-A Triorganomonohalogenosilane SHIN-ETSU CHEMICAL CO., LTD. (JP) 1994-08-30 US disclosed
EP-0577139-A1 Method for preparing triorganomonohalogenosilane Shin-Etsu Chemical Co., Ltd. (JP) 1994-01-05 EP disclosed
US-5240813-A POLYSILPHENYLENESILOXANE, PRODUCTION PROCESS THEREOF, AND RESIST MATERIAL AND SEMICONDUCTOR DEVICE FORMED THEREOF FUJITSU LIMITED (JP) 1993-08-31 US disclosed
EP-0432905-A2 Polyisophenylenesiloxane, production process thereof, and resist material and semiconductor device formed thereof FUJITSU LIMITED (JP) 1991-06-19 EP disclosed
US-4696827-A CARBONIZATION OF POLYMERS SONY CORPORATION (JP) 1987-09-29 US disclosed
JP-S62108885-A ORGANOSILICON COMPOUND, PRODUCTION THEREOF AND INSECTICIDE CONTAINING SAID COMPOUND MITSUI TOATSU CHEM INC 1987-05-20 JP disclosed
US-4618591-A MOLDING MATERIALS FOR FINE AND COMPLICATED SHAPES SONY CORPORATION (JP) 1986-10-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170036200-A1 1-HEXENE PRODUCTION PROCESS AP1M1, HK1, CYC1 LMNA 4214/4885CYP2A6 398/4885IDO1 1185/4885
US-20150105572-A1 TRANSITION METAL COMPLEX AP1M1, AP3M1, EMC1 LMNA 3476/4885CYP2A6 1252/4885IDO1 2333/4885
US-20150105237-A1 CATALYTIC COMPONENT FOR TRIMERIZATION AND TRIMERIZATION CATALYST AP1M1, AMY1A, AP3M1 LMNA 3976/4885CYP2A6 720/4885IDO1 1530/4885
US-20120184431-A1 TRANSITION METAL COMPLEX, PREPARATION METHOD FOR SAID TRANSITION METAL COMPLEX, TRIMERIZATION CATALYST, PREPARATION METHOD FOR 1-HEXENE, PREPARATION METHOD FOR ETHYLENE POLYMER, SUBSTITUTED CYCLOPENTADIENE COMPOUND, AND PREPARATION METHOD FOR SAID SUBSTITUTED CYCLOPENTADIENE COMPOUND EMC1, CYC1, AP1M1 LMNA 2944/4885CYP2A6 525/4885IDO1 2122/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.